Overview

This trial is active, not recruiting.

Condition multiple myeloma
Treatment administering three additional mri images
Sponsor University of Arkansas
Collaborator Siemens Molecular Imaging
Start date June 2009
End date March 2016
Trial size 100 participants
Trial identifier NCT01018927, 110104

Summary

The purpose of this study is to see if MRI techniques can be used for early evaluation of cardiac amyloidosis which is sometimes seen in individuals with multiple myeloma. Cardiac amyloidosis is a medical disorder that decreases heart function.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Time perspective prospective
Arm
Prospective review of 100 CMR studies performed on multiple myeloma patients referred for cardiac evaluation by MRI. Three additional MRI images will be performed to determine the role of cardiac MR (CMR) in detecting features of early myocardial infiltration
administering three additional mri images
Three additional MRI images to determine the role of cardiac MR (CMR) in detecting features of early myocardial infiltration

Primary Outcomes

Measure
This study is to see if MRI techniques can be used for early evaluation of cardiac amyloidosis which is sometimes seen in individuals with multiple myeloma.
time frame: The time frame is five additional minutes & three additional images during and MRI.

Eligibility Criteria

Male or female participants from 18 years up to 80 years old.

Inclusion Criteria: - All races and ethnic groups - Male and female ages 18-80 years of age - History of multiple myeloma - CMR study for evaluation for cardiac amyloidosis Exclusion Criteria: - Pregnant women - Subject with a metallic or electronic or other device that could be affected by the magnet

Additional Information

Official title Role of Cardiac MR (CMR) In Detecting Features of Early Myocardial Infiltration With Amyloid and Light Chain Deposition Disease in Subjects With Multiple Myeloma
Principal investigator Kedar Jambhekar, MD
Description The purpose is to investigate the use of multiple newer CMR techniques for early evaluation of cardiac amyloidosis in multiple myeloma.
Trial information was received from ClinicalTrials.gov and was last updated in April 2015.
Information provided to ClinicalTrials.gov by University of Arkansas.